Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has acted as counsel for VGS Aircraft Holding (Ireland) Limited
Mandate

Vinge has acted as counsel for VGS Aircraft Holding (Ireland) Limited

February 21, 2011

Vinge has acted as counsel for three of the subsidaries of VGS Aircraft Holding (Ireland) Limited in connection with various aircraft transactions: 

  • Johannesburg Limited and Olbia Limited in connection with the refinancing of a fleet of 10 aircraft. The lender to the subsidiaries is GE Japan Corporation. 
  • VGS Investments One Limited in connection with the lease of an aircraft to the airline SIA Smartlynx Airlines. The lender to VGS Investments Limited is Norddeutsche Landesbank. 
  • Olbia Limited in connection with the financing and lease of an aircraft to the airline Jet2.com and in connection with the acquisition, financing and lease of two aircraft to the airline Air Berlin. The lender to Olbia Limited is GE Japan Corporation. 
  • Johannesburg Limited in connection with the refinancing of seven aircraft. Lender to Johannesburg Limited is HSH Nordbanks AG. 


VGS Aircraft Holding (Ireland) Limited is a joint venture between Volito Aviation AB and a company within the Goldman Sachs Group.

Vinges team consisted of among others Henrik Ossborn, Johan Ragnar and Susanne Samuelsson.

Related

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

 Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024

Vinge advises Triton in connection with the divestment of Norstat to Nalka Invest

Vinge advises Triton Smaller Mid-Cap Fund I (“Triton”) in connection with the divestment of Norstat, a leading data collector for market research, to Nalka Invest.
April 12, 2024